Literature DB >> 21790280

Disease-modifying drugs for systemic sclerosis: why have we not found them yet?

Chris T Derk.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21790280     DOI: 10.1586/eci.11.29

Source DB:  PubMed          Journal:  Expert Rev Clin Immunol        ISSN: 1744-666X            Impact factor:   4.473


× No keyword cloud information.
  3 in total

Review 1.  Personalized medicine in systemic sclerosis: facts and promises.

Authors:  Rucsandra Dobrota; Carina Mihai; Oliver Distler
Journal:  Curr Rheumatol Rep       Date:  2014-06       Impact factor: 4.592

2.  Disease modification in systemic sclerosis. Do integrated approaches offer new challenges?

Authors:  M Cutolo
Journal:  Z Rheumatol       Date:  2013-05       Impact factor: 1.372

3.  Update on management of connective tissue panniculitides.

Authors:  Inbal Braunstein; Victoria P Werth
Journal:  Dermatol Ther       Date:  2012 Mar-Apr       Impact factor: 2.851

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.